Literature DB >> 16220917

Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen.

Jeremiah S Helm1, Yanan Hu, Lan Chen, Ben Gross, Suzanne Walker.   

Abstract

MurG is a glycosyltransferase involved in the biosynthesis of bacterial peptidoglycan. It is a potentially important antibiotic target, but no inhibitors of the enzyme have been reported. In general, inhibitors of glycosyltransferases have been difficult to design. Furthermore, no glycosyltransferase inhibitors have been identified through high-throughput screening, perhaps because appropriate screens for glycosyltransferase inhibition have not been developed. In this manuscript, we describe the development of a high-throughput screen for MurG that was used to screen a 50 000 compound library for inhibitors. The screen, which can be generalized to other glycosyltransferases, led to the identification of a family of active-site directed MurG inhibitors. The family of inhibitors contains a five-membered heterocyclic core that appears to function as a diphosphate mimic with respect to the presentation of substituents. We discuss the implications of this result and the utility of the screen for identifying inhibitors of other glycosyltransferases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 16220917     DOI: 10.1021/ja036494s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  26 in total

1.  Substrate Tolerance of Bacterial Glycosyltransferase MurG: Novel Fluorescence-Based Assays.

Authors:  Katsuhiko Mitachi; Hyun Gi Yun; Cody D Gillman; Karolina Skorupinska-Tudek; Ewa Swiezewska; William M Clemons; Michio Kurosu
Journal:  ACS Infect Dis       Date:  2019-12-11       Impact factor: 5.084

2.  Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.

Authors:  Sudha Ravishankar; Vidya Prasanna Kumar; B Chandrakala; Ramesh K Jha; Suresh M Solapure; Sunita M de Sousa
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Non-carbohydrate inhibitors of the lectin DC-SIGN.

Authors:  M Jack Borrok; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

4.  Improved synthesis of capuramycin and its analogues.

Authors:  Yong Wang; Shajila Siricilla; Bilal A Aleiwi; Michio Kurosu
Journal:  Chemistry       Date:  2013-09-06       Impact factor: 5.236

5.  First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.

Authors:  Terry K Smith; Benjamin L Young; Helen Denton; David L Hughes; Gerd K Wagner
Journal:  Bioorg Med Chem Lett       Date:  2009-01-30       Impact factor: 2.823

6.  Identifying essential genes in bacterial metabolic networks with machine learning methods.

Authors:  Kitiporn Plaimas; Roland Eils; Rainer König
Journal:  BMC Syst Biol       Date:  2010-05-03

7.  A small molecule that inhibits OGT activity in cells.

Authors:  Rodrigo F Ortiz-Meoz; Jiaoyang Jiang; Michael B Lazarus; Marina Orman; John Janetzko; Chenguang Fan; Damien Y Duveau; Zhi-Wei Tan; Craig J Thomas; Suzanne Walker
Journal:  ACS Chem Biol       Date:  2015-03-18       Impact factor: 5.100

8.  Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial Agents.

Authors:  Virginia A Kincaid; Nir London; Kittikhun Wangkanont; Darryl A Wesener; Sarah A Marcus; Annie Héroux; Lyudmila Nedyalkova; Adel M Talaat; Katrina T Forest; Brian K Shoichet; Laura L Kiessling
Journal:  ACS Chem Biol       Date:  2015-08-17       Impact factor: 5.100

9.  Concise synthesis of capuramycin.

Authors:  Michio Kurosu; Kai Li; Dean C Crick
Journal:  Org Lett       Date:  2009-06-04       Impact factor: 6.005

Review 10.  Lipid intermediates in the biosynthesis of bacterial peptidoglycan.

Authors:  Jean van Heijenoort
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.